We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
We will guide you from your first visit to the centre, allowing you to find all the departments and make the most of our facilities. Whatever the reason for your visit, we will explain how to get about the hospital.
The Bone Metabolism Unit (UMO) focuses on detecting, treating, and monitoring patients with metabolic bone disorders. Our specialized care comprises pathologies ranging from osteoporosis, which is the most common of these disorders, to Paget's disease and osteomalacia, and includes rare diseases like osteogenesis imperfecta.
We concern ourselves with detecting, treating, and monitoring patients with premenopausal, postmenopausal, and male osteoporosis, along with osteoporosis that can appear secondary to drugs and other diseases, such as transplants, blood and endocrine diseases, HIV infection, bariatric surgery, breast cancer, and chronic kidney failure. These pathologies can, through various mechanisms, cause osteoporosis. That is why we actively monitor these patients, coordinating with the different specialities treating them.
In this line, we carry out important healthcare and research work in osteoporosis related to lung transplant, actively evaluating the patients and carrying out protocol-based, multidisciplinary treatment and follow-up to minimise the risk of fractures and avoid the associated complications. The fact that the Vall d'Hebron University Hospital is the only centre in Catalonia authorised to do lung transplants means that we have extensive healthcare activity and experience in this field.
The Fracture Liaison Unit (UCF) for the North Primary Health Care Area (AIS Nord) is in the process of being created and inaugurated. Fracture Liaison Units (FLS) are multidisciplinary services whose objective is the secondary prevention of fractures due to bone fragility (those produced by a light impact or mild fall). The first fragility fracture is a predictor for subsequent fractures and is associated with very high morbidity, mortality, and socioeconomic costs, especially when it is a hip fracture. Fracture Liaison Units have been implemented in many countries and there are many publications that substantiate their effectiveness and clinical potential (https://www.capturethefracture.org/). Thus, our objective is based on offering a patient who has suffered a first fragility fracture timely, comprehensive, protocol-based, and high-quality care.
In addition, we are actively involved in the less prevalent bone metabolism disorders, such as Paget's disease and osteomalacia, as well as rare disorders like osteogenesis imperfecta, which require coordinated care with different medical and surgical specialities and a close, multidisciplinary monitoring.
Traumatology, Rehabilitation and Burns Hospital
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to email@example.com, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.